<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39333516</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 spike-specific nasal-resident CD49a<sup>+</sup>CD8<sup>+</sup> memory T cells exert immediate effector functions with enhanced IFN-γ production.</ArticleTitle><Pagination><StartPage>8355</StartPage><MedlinePgn>8355</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8355</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-024-52689-5</ELocationID><Abstract><AbstractText>Virus-specific nasal resident T cells are important for protection against subsequent infection with a similar virus. Here we examine the phenotypes and functions of SARS-CoV-2-specific T cells in the nasal mucosa of vaccinated individuals with breakthrough infection (BTI) or without infection. Nasal tissues are obtained from participants during sinus surgery. Analysis of activation-induced markers implicates that a considerable proportion of spike (S)-reactive nasal CD8<sup>+</sup> T cells express CD103, a tissue-resident marker. MHC-I multimer staining is performed to analyze the ex vivo phenotype and function of SARS-CoV-2 S-specific CD8<sup>+</sup> T cells. We detect multimer<sup>+</sup>CD8<sup>+</sup> T cells with tissue-resident phenotypes in nasal tissue samples from vaccinees without infection as well as vaccinees with BTI. Multimer<sup>+</sup>CD8<sup>+</sup> T cells remain present in nasal tissues over one year after the last exposure to S antigen, although the frequency decreases. Upon direct ex vivo stimulation with epitope peptides, nasal multimer<sup>+</sup>CD8<sup>+</sup> T cells-particularly the CD49a<sup>+</sup> subset-exhibit immediate effector functions, including IFN-γ production. CITE-seq analysis of S-reactive AIM<sup>+</sup>CD8<sup>+</sup> T cells confirms the enhanced effector function of the CD49a<sup>+</sup> subset. These findings indicate that among individuals previously exposed to S antigen by vaccination or BTI, S-specific nasal-resident CD49a<sup>+</sup>CD8<sup>+</sup> memory T cells can rapidly respond to SARS-CoV-2 during infection or reinfection.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rha</LastName><ForeName>Min-Seok</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0003-1426-7534</Identifier><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Airway Mucus Institute, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Gyeongyeob</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-7972-1446</Identifier><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sol</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jihye</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Center for Viral Immunology, Korea Virus Research Institute, Institute for Basic Science, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>Yeonsu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Chan Min</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noh</LastName><ForeName>Hae Eun</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noh</LastName><ForeName>Ji Yun</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yong Min</ForeName><Initials>YM</Initials><Identifier Source="ORCID">0000-0001-5414-8332</Identifier><AffiliationInfo><Affiliation>Department of Otorhinolaryngology-Head and Neck Surgery, Research Institute for Medical Science, Chungnam National University School of Medicine, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Science, Chungnam National University School of Medicine, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Hyung-Ju</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Airway Mucus Institute, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Chang-Hoon</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Republic of Korea. entman@yuhs.ac.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Airway Mucus Institute, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea. entman@yuhs.ac.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Eui-Cheol</ForeName><Initials>EC</Initials><Identifier Source="ORCID">0000-0002-6308-9503</Identifier><AffiliationInfo><Affiliation>The Center for Viral Immunology, Korea Virus Research Institute, Institute for Basic Science, Daejeon, Republic of Korea. ecshin@kaist.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea. ecshin@kaist.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RS-2023-00222762</GrantID><Agency>National Research Foundation of Korea (NRF)</Agency><Country /></Grant><Grant><GrantID>HI23C1464</GrantID><Agency>Korea Health Industry Development Institute (KHIDI)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>82115-62-6</RegistryNumber><NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D039423">Integrin alpha1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015703">Antigens, CD</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C091367">alpha E integrins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D039001">Integrin alpha Chains</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="Y">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="Y">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007371" MajorTopicYN="Y">Interferon-gamma</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009297" MajorTopicYN="Y">Nasal Mucosa</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000091246" MajorTopicYN="Y">Memory T Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039423" MajorTopicYN="N">Integrin alpha1</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015703" MajorTopicYN="N">Antigens, CD</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007156" MajorTopicYN="N">Immunologic Memory</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039001" MajorTopicYN="N">Integrin alpha Chains</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>9</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>23</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39333516</ArticleId><ArticleId IdType="pmc">PMC11436836</ArticleId><ArticleId IdType="doi">10.1038/s41467-024-52689-5</ArticleId><ArticleId IdType="pii">10.1038/s41467-024-52689-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sekine, T. et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell183, 158–168.e14 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7427556</ArticleId><ArticleId IdType="pubmed">32979941</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan, J. M. et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science371, eabf4063 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7919858</ArticleId><ArticleId IdType="pubmed">33408181</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateus, J. et al. Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells. Science374, eabj9853 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8542617</ArticleId><ArticleId IdType="pubmed">34519540</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin, U. et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature595, 572–577 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34044428</ArticleId></ArticleIdList></Reference><Reference><Citation>Wherry, E. J. &amp; Barouch, D. H. T cell immunity to COVID-19 vaccines. Science377, 821–822 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35981045</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarke, A. et al. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron. Cell185, 847–859.e11 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8784649</ArticleId><ArticleId IdType="pubmed">35139340</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung, M. K. et al. BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality. Nat. Microbiol7, 909–917 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35577972</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao, Y. et al. Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant. Nat. Med. 28, 472–476 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938268</ArticleId><ArticleId IdType="pubmed">35042228</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahan, K. et al. Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature590, 630–634 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906955</ArticleId><ArticleId IdType="pubmed">33276369</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller, S. N. &amp; Mackay, L. K. Tissue-resident memory T cells: local specialists in immune defence. Nat. Rev. Immunol.16, 79–89 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26688350</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo, P. A., Miron, M. &amp; Farber, D. L. Location, location, location: Tissue resident memory T cells in mice and humans. Sci. Immunol.4, eaas9673 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6778482</ArticleId><ArticleId IdType="pubmed">30952804</ArticleId></ArticleIdList></Reference><Reference><Citation>Masopust, D. &amp; Soerens, A. G. Tissue-resident T cells and other resident leukocytes. Annu Rev. Immunol.37, 521–546 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7175802</ArticleId><ArticleId IdType="pubmed">30726153</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzolla, A. et al. Resident memory CD8(+) T cells in the upper respiratory tract prevent pulmonary influenza virus infection. Sci. Immunol.2, eaam6970 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28783656</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinnear, E. et al. Airway T cells protect against RSV infection in the absence of antibody. Mucosal Immunol.11, 249–256 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28537249</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, J. et al. Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses. Immunity44, 1379–1391 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4917442</ArticleId><ArticleId IdType="pubmed">27287409</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn, J. H. et al. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19. J. Clin. Invest131, e148517 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8245175</ArticleId><ArticleId IdType="pubmed">34003804</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon, M. M. L. et al. SARS-CoV-2 infection generates tissue-localized immunological memory in humans. Sci. Immunol.6, eabl9105 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8626868</ArticleId><ArticleId IdType="pubmed">34618554</ArticleId></ArticleIdList></Reference><Reference><Citation>Roukens, A. H. E. et al. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8(+) T cell responses following COVID-19. Nat. Immunol.23, 23–32 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34937933</ArticleId></ArticleIdList></Reference><Reference><Citation>Ssemaganda, A. et al. Expansion of cytotoxic tissue-resident CD8(+) T cells and CCR6(+)CD161(+) CD4(+) T cells in the nasal mucosa following mRNA COVID-19 vaccination. Nat. Commun.13, 3357 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9186487</ArticleId><ArticleId IdType="pubmed">35688805</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunzli, M. et al. Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells. Sci. Immunol.7, eadd3075 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9832918</ArticleId><ArticleId IdType="pubmed">36459542</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim, J. M. E. et al. SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity. J. Exp. Med. 219, e20220780 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9386509</ArticleId><ArticleId IdType="pubmed">35972472</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang, J. et al. Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination. Sci. Immunol.7, eadd4853 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9348751</ArticleId><ArticleId IdType="pubmed">35857583</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsi, E. et al. Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination. Nat. Commun.14, 6815 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10603102</ArticleId><ArticleId IdType="pubmed">37884506</ArticleId></ArticleIdList></Reference><Reference><Citation>Carabelli, A. M. et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat. Rev. Microbiol21, 162–177 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9847462</ArticleId><ArticleId IdType="pubmed">36653446</ArticleId></ArticleIdList></Reference><Reference><Citation>Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell181, 1489–1501.e15 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237901</ArticleId><ArticleId IdType="pubmed">32473127</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bert, N. et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature584, 457–462 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32668444</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelde, A. et al. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition. Nat. Immunol.22, 74–85 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32999467</ArticleId></ArticleIdList></Reference><Reference><Citation>Low, J. S. et al. Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2. Science372, 1336–1341 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168615</ArticleId><ArticleId IdType="pubmed">34006597</ArticleId></ArticleIdList></Reference><Reference><Citation>Rha, M. S. et al. PD-1-expressing SARS-CoV-2-specific CD8(+) T cells are not exhausted, but functional in patients with COVID-19. Immunity54, 44–52.e3 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834198</ArticleId><ArticleId IdType="pubmed">33338412</ArticleId></ArticleIdList></Reference><Reference><Citation>Wein, A. N. et al. CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways. J. Exp. Med. 216, 2748–2762 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6888981</ArticleId><ArticleId IdType="pubmed">31558615</ArticleId></ArticleIdList></Reference><Reference><Citation>Rydyznski Moderbacher, C. et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell183, 996–1012.e19 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7494270</ArticleId><ArticleId IdType="pubmed">33010815</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung, J. H. et al. SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells. Nat. Commun.12, 4043 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8245549</ArticleId><ArticleId IdType="pubmed">34193870</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowntree, L. C. et al. SARS-CoV-2-specific CD8(+) T-cell responses and TCR signatures in the context of a prominent HLA-A*24:02 allomorph. Immunol. Cell Biol.99, 990–1000 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242669</ArticleId><ArticleId IdType="pubmed">34086357</ArticleId></ArticleIdList></Reference><Reference><Citation>Park, S. H. et al. Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus. Gastroenterology143, 1048–1060.e4 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3458177</ArticleId><ArticleId IdType="pubmed">22705008</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar, B. V. et al. Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites. Cell Rep.20, 2921–2934 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5646692</ArticleId><ArticleId IdType="pubmed">28930685</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray, J. I. &amp; Farber, D. L. Tissue-resident immune cells in humans. Annu Rev. Immunol.40, 195–220 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11194112</ArticleId><ArticleId IdType="pubmed">35044795</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly, E. C. et al. CD49a identifies polyfunctional memory CD8 T cell subsets that persist in the lungs after influenza infection. Front Immunol.12, 728669 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8462271</ArticleId><ArticleId IdType="pubmed">34566986</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheuk, S. et al. CD49a expression defines tissue-resident CD8(+) T cells poised for cytotoxic function in human skin. Immunity46, 287–300 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5337619</ArticleId><ArticleId IdType="pubmed">28214226</ArticleId></ArticleIdList></Reference><Reference><Citation>Azizi, E. et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell174, 1293–1308.e36 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6348010</ArticleId><ArticleId IdType="pubmed">29961579</ArticleId></ArticleIdList></Reference><Reference><Citation>Pipkorn, U. &amp; Karlsson, G. Methods for obtaining specimens from the nasal mucosa for morphological and biochemical analysis. Eur. Respir. J.1, 856–862 (1988).</Citation><ArticleIdList><ArticleId IdType="pubmed">3068074</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordovas-Montanes, J. et al. Allergic inflammatory memory in human respiratory epithelial progenitor cells. Nature560, 649–654 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6133715</ArticleId><ArticleId IdType="pubmed">30135581</ArticleId></ArticleIdList></Reference><Reference><Citation>Woon, H. G. et al. Compartmentalization of total and virus-specific tissue-resident memory CD8+ T cells in human lymphoid organs. PLoS Pathog.12, e1005799 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4991796</ArticleId><ArticleId IdType="pubmed">27540722</ArticleId></ArticleIdList></Reference><Reference><Citation>Niessl, J. et al. Identification of resident memory CD8(+) T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue. Sci. Immunol.6, eabk0894 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10763663</ArticleId><ArticleId IdType="pubmed">34519539</ArticleId></ArticleIdList></Reference><Reference><Citation>Diniz, M. O. et al. Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2. Nat. Immunol.23, 1324–1329 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9477726</ArticleId><ArticleId IdType="pubmed">36038709</ArticleId></ArticleIdList></Reference><Reference><Citation>Masopust, D. et al. Dynamic T cell migration program provides resident memory within intestinal epithelium. J. Exp. Med. 207, 553–564 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2839151</ArticleId><ArticleId IdType="pubmed">20156972</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagama, Y. et al. Detecting waning serological response with commercial immunoassays: 18-Month longitudinal follow-up of anti-SARS-CoV-2 nucleocapsid antibodies. Microbiol Spectr.10, e0098622 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9430644</ArticleId><ArticleId IdType="pubmed">35867423</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>